Osage University Partners has contributed to an $80m round for Dice Molecules, which is advancing Stanford University research and is also backed by Sanofi and Alexandria.
Dice Molecules, a US-based biopharmaceutical spinout of Stanford University, closed an $80m series C round on Friday featuring spinout-focused investment firm Osage University Partners.
RA Capital Management led the round, which also attracted Sanofi Ventures and Alexandria Venture Investments on behalf of pharmaceutical firm Sanofi and real estate investment trust Alexandria Real Estate Equities.
Eventide Asset Management, New Leaf Venture Partners, Soleus Capital, Driehaus Capital Management, Asymmetry Capital Management, Northpond Ventures, Sands Capital, Altitude Life Science Ventures and…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
